Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)
13.42
+0.35 (2.68%)
Oct 23, 2026, 3:00 PM CST
SHA:600129 Revenue
Chongqing Taiji Industry(Group) Co.,Ltd had revenue of 2.56B CNY in the quarter ending June 30, 2026, a decrease of -9.66%. This brings the company's total for the last twelve months to 9.93B, down -2.93% year-over-year. In the year 2025, Chongqing Taiji Industry(Group) Co.,Ltd had annual revenue of 10.50B, down -15.23%. That makes Chongqing Taiji Industry(Group) Co.,Ltd the 5,993rd largest company in the world by revenue and 800th in China.
Revenue (ttm)
9.93B
Revenue Growth
-2.93%
P/S Ratio
0.75
Revenue / Employee
913.75K
Employees
10,864
Market Cap
7.40B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:600129 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.50B | -1.89B | -15.23% |
| Dec 31, 2024 | 12.39B | -3.24B | -20.72% |
| Dec 31, 2023 | 15.62B | 1.50B | 10.58% |
| Dec 31, 2022 | 14.13B | 1.98B | 16.28% |
| Dec 31, 2021 | 12.15B | 941.63M | 8.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shandong Lukang Pharmaceutical | 5.85B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Beijing Foyou Pharma CO.,LTD | 3.58B |
| Tianjin Ringpu Bio-Technology | 3.41B |
| Jiangsu Kanion Pharmaceutical | 3.31B |
| Zhejiang Tianyu Pharmaceutical | 3.30B |
| Jiuzhitang | 2.60B |
| Guilin Sanjin Pharmaceutical | 2.02B |